Skip to main content
Caplight Logo









Dopavision

Dopavision

Private
BerlinHealthcare & Life Scienceshttps://dopavision.com/

Last Round

Series A

Jul 14, 2021

Total Funding Raised

$17.19M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Dopavision is a biotechnology company that develops digital therapeutics for the management of myopia in children and adolescents.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Patient Engagement

Business Model

B2B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

digital therapeuticsDTxmyopia managementchildhood myopiaphotobiomodulationnearsightedness treatmentlight-based therapyVR therapyophthalmologyprescription digital therapeuticseye care technologynon-invasive treatmentpediatric eye healthhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dopavision Comparables

Compare Dopavision with similar companies based on industry and business-model similarity.

Dopavision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eyerising International
84%
NovaSight
82%
Luminopia, Inc.
80%

Dopavision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 14, 2021
SeedMay 1, 2019

Key People

Founding team and executive leadership

Mark Wuttke

Chief Executive Officer

Executive Team

Andreas Balser

Chief Technology Officer

Executive Team

Dopavision Investors

Notable investors and investment history

Dopavision investors
InvestorRounds
Boehringer Ingelheim Venture FundSeries A, Seed
Seventure PartnersSeries A
Flying HealthSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 160% MoM.

  • Mar 1, 2026

    Monthly visitors increased 234% MoM.

Dopavision Filings

Explore SEC and related filing metadata, where available.

Dopavision filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dopavision's valuation, stock price, and market status.

Is Dopavision a public or private company?

Dopavision is a private company.

What is the current stock price of Dopavision?

Dopavision is a private company with no public stock price. No recent secondary market data is available.

How much is Dopavision worth (valuation)?

Valuation information for Dopavision is not publicly available.

Can I buy Dopavision stock?

Dopavision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dopavision's last funding round?

Dopavision's most recent funding round was Series A on July 14, 2021.

Who are the main investors in Dopavision?

Key investors in Dopavision include Boehringer Ingelheim Venture Fund, Seventure Partners.

Will Dopavision IPO soon?

No public IPO plans have been announced for Dopavision.

How can I track Dopavision secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dopavision's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range9
Year Founded2017
Last FundingJul 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?